Perspective Therapeutics, Inc. (CATX) is a publicly traded Healthcare sector company. As of November 6, 2026, CATX trades at $0.79 with a market cap of $99.33M and a P/E ratio of -1.89. CATX moved -7.55% today. Year to date, CATX is -71.21%; over the trailing twelve months it is -66.27%. Its 52-week range spans $0.79 to $6.16. Analyst consensus is strong buy with an average price target of $10.18. Rallies surfaces CATX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies community data for CATX shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
| Metric | Value |
|---|---|
| Price | $0.79 |
| Market Cap | $99.33M |
| P/E Ratio | -1.89 |
| EPS | $-1.23 |
| Dividend Yield | 0.00% |
| 52-Week High | $6.16 |
| 52-Week Low | $0.79 |
| Volume | 3.70M |
| Avg Volume | 0 |
| Revenue (TTM) | $1.45M |
| Net Income | $-81.38M |
| Gross Margin | 0.00% |
12 analysts cover CATX: 0 strong buy, 10 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $10.18.